154 related articles for article (PubMed ID: 26885218)
1. Clinicopathological significance of Sox2 expression in patients with breast cancer: a meta-analysis.
Zheng Y; Qin B; Li F; Xu S; Wang S; Li L
Int J Clin Exp Med; 2015; 8(12):22382-92. PubMed ID: 26885218
[TBL] [Abstract][Full Text] [Related]
2. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis.
Zhao G; Wang X; Qu L; Zhu Z; Hong J; Hou H; Li Z; Wang J; Lv Z
Breast Care (Basel); 2021 Feb; 16(1):16-26. PubMed ID: 33716628
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic role of SIRT1 in breast cancer patients: a meta-analysis.
Cao YW; Li YC; Wan GX; Du XM; Li F
Int J Clin Exp Med; 2015; 8(1):616-24. PubMed ID: 25785036
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of SOX2 in head and neck cancer: a meta-analysis.
Dong Z; Liu G; Huang B; Sun J; Wu D
Int J Clin Exp Med; 2014; 7(12):5010-20. PubMed ID: 25664000
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis.
Li Z; Yin S; Zhang L; Liu W; Chen B; Xing H
Onco Targets Ther; 2017; 10():859-870. PubMed ID: 28243121
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis.
Liu B; Peng Q; Wang YW; Qiu J; Zhu J; Ma R
Front Oncol; 2023; 13():1153076. PubMed ID: 37124526
[TBL] [Abstract][Full Text] [Related]
8. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.
Zhang X; Xing C; Guan W; Chen L; Guo K; Yu A; Xie K
Cancer Cell Int; 2020; 20():169. PubMed ID: 32467665
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
Zhang Z; Fang T; Lv Y
World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis.
He K; Zeng H; Xu X; Li A; Cai Q; Long X
Exp Ther Med; 2016 Jun; 11(6):2525-2530. PubMed ID: 27284343
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis.
Huang G; Zhang J; Wang X; Chen Y; Liu D; Guo S
Onco Targets Ther; 2019; 12():3609-3617. PubMed ID: 31190863
[No Abstract] [Full Text] [Related]
13. SOX2 contributes to invasion and poor prognosis of gastric cancer: A meta-analysis.
Tang K; Liu J; Liu B; Meng C; Liao J
Medicine (Baltimore); 2022 Sep; 101(36):e30559. PubMed ID: 36086709
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological value of CXCL12/SDF1 expression in breast cancer: A meta-analysis.
Liu H; Li Z; Deng M; Liu Q; Zhang T; Guo W; Li P; Qiao W
Clin Chim Acta; 2018 Sep; 484():72-80. PubMed ID: 29800557
[TBL] [Abstract][Full Text] [Related]
15. Expression of sex-determining region Y-box protein 2 in breast cancer and its clinical significance.
Feng X; Lu M
Saudi Med J; 2017 Jul; 38(7):685-690. PubMed ID: 28674712
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis.
Kim HM; Lee J; Koo JS
BMC Cancer; 2017 Oct; 17(1):690. PubMed ID: 29041905
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
18. Survival and clinicopathological significance of blood vessel invasion in operable breast cancer: a systematic review and meta-analysis.
Lin Y; Zhang Y; Fang H; Hu Q; Duan H; Zhang L; Pang D
Jpn J Clin Oncol; 2023 Jan; 53(1):35-45. PubMed ID: 36156086
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
20. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
